全文获取类型
收费全文 | 5856篇 |
免费 | 437篇 |
国内免费 | 33篇 |
专业分类
耳鼻咽喉 | 68篇 |
儿科学 | 191篇 |
妇产科学 | 124篇 |
基础医学 | 697篇 |
口腔科学 | 207篇 |
临床医学 | 444篇 |
内科学 | 1401篇 |
皮肤病学 | 152篇 |
神经病学 | 315篇 |
特种医学 | 127篇 |
外国民族医学 | 4篇 |
外科学 | 879篇 |
综合类 | 209篇 |
一般理论 | 2篇 |
预防医学 | 453篇 |
眼科学 | 110篇 |
药学 | 555篇 |
中国医学 | 69篇 |
肿瘤学 | 319篇 |
出版年
2023年 | 88篇 |
2022年 | 46篇 |
2021年 | 333篇 |
2020年 | 185篇 |
2019年 | 230篇 |
2018年 | 223篇 |
2017年 | 177篇 |
2016年 | 225篇 |
2015年 | 234篇 |
2014年 | 275篇 |
2013年 | 353篇 |
2012年 | 521篇 |
2011年 | 549篇 |
2010年 | 276篇 |
2009年 | 226篇 |
2008年 | 352篇 |
2007年 | 284篇 |
2006年 | 297篇 |
2005年 | 286篇 |
2004年 | 222篇 |
2003年 | 178篇 |
2002年 | 176篇 |
2001年 | 29篇 |
2000年 | 39篇 |
1999年 | 45篇 |
1998年 | 38篇 |
1997年 | 24篇 |
1996年 | 22篇 |
1995年 | 26篇 |
1994年 | 27篇 |
1993年 | 22篇 |
1992年 | 22篇 |
1991年 | 11篇 |
1990年 | 29篇 |
1989年 | 30篇 |
1988年 | 22篇 |
1987年 | 26篇 |
1986年 | 17篇 |
1985年 | 9篇 |
1984年 | 15篇 |
1983年 | 17篇 |
1982年 | 19篇 |
1981年 | 12篇 |
1980年 | 8篇 |
1979年 | 8篇 |
1977年 | 9篇 |
1976年 | 7篇 |
1975年 | 8篇 |
1974年 | 6篇 |
1973年 | 5篇 |
排序方式: 共有6326条查询结果,搜索用时 967 毫秒
1.
2.
3.
4.
5.
Evaluation of NMU-Induced Breast Cancer Treated with Sirolimus and Sunitinib on Breast Cancer Growth 下载免费PDF全文
Nurul Fathiyatul Nabila JaffarMuhammad Shahidan Muhammad SakriHasnan JaafarWan Faiziah Wan Abdul RahmanTengku Ahmad Damitri Al-Astani Tengku Din 《Asian Pacific journal of cancer prevention》2020,21(10):2919-2925
Objective: To analyze the effect of sirolimus and sunitinib in blocking the tumor growth and to evaluate the expressions of estrogen receptor (ER), progesterone receptor (PgR), and human epidermal growth factor receptor-2 (HER2/neu) after treated with sirolimus and sunitinib. Methods: Thirty-two female Sprague Dawley rats at age 21-days old were administered intraperitoneally with N-Methyl-N-Nitroso Urea (NMU), dosed at 70mg/kg body weight. The rats were divided into 4 groups; Group 1 (Control, n=8), Group 2 (Sirolimus, n=8), Group 3 (Sunitinib, n=8) and Group 4 (Sirolimus+Sunitinib, n=8), being treated twice when the tumor reached the size of 14.5±0.5 mm and subsequently sacrificed after 5 days. The protein expressions of ER, PgR and HER2/neu of the tumor tissues were evaluated by using immunohistochemistry analysis. Results: Treatment with sirolimus alone lowered expressions of ER and PgR of breast cancer and reduced tumor size. There was no significant difference of ER and PgR expressions between control and sunitinib treated tumor. Sunitinib treated tumors reduce in diameter after the first treatment, however the diameter increases after the second treatment. Histologically, sunitinib treated tumor did not show any aggressive invasive carcinoma of no special type (NST) histological subtypes. In addition, all NMU-induced tumors are HER2/neu-negative scoring. Conclusion: Sirolimus is neither synergistic nor additive with sunitinib for breast cancer treatment. 相似文献
6.
Sami Al-Said Ammar Ali Abdul Kader Alobaidy Emad Mojeeb Abdulla Al-Naimi Ahmed A Shokeir 《International journal of urology》2007,14(5):452-454
Xanthogranulomatous orchitis is an extremely rare inflammatory non-neoplastic destructive lesion of the testis. We report a 44-year-old man who presented with right scrotal swelling and two discharging sinuses. Testicular tumor markers were normal. Scrotal ultrasound showed heterogeneous testicular areas and irregular margin of the tunica. Surgical exploration revealed infected, unhealthy testicular tissue with necrosis and tumor-like lesion. Orchidectomy was done and histopathology showed xanthogranulomatous orchitis. 相似文献
7.
8.
Abdul Ahad 《Indian journal of otolaryngology and head and neck surgery》1997,49(4):341-343
Tumours of the nerve sheath origin in the head and neck are not common. Schwannomas are rare. Only a few cases have been reported so far. We report a rare case of Schwannoma of Submandibular region arising from the lingual nerve. 相似文献
9.
The insulinotropic potency of fatty acids is influenced profoundly by their chain length and degree of saturation. 总被引:16,自引:2,他引:14 下载免费PDF全文
D T Stein B E Stevenson M W Chester M Basit M B Daniels S D Turley J D McGarry 《The Journal of clinical investigation》1997,100(2):398-403
Lowering of the elevated plasma FFA concentration in 18- 24-h fasted rats with nicotinic acid (NA) caused complete ablation of subsequent glucose-stimulated insulin secretion (GSIS). Although the effect of NA was reversed when the fasting level of total FFA was maintained by coinfusion of soybean oil or lard oil (plus heparin), the more saturated animal fat proved to be far more potent in enhancing GSIS. We therefore examined the influence of individual fatty acids on insulin secretion in the perfused rat pancreas. When present in the perfusion fluid at 0.5 mM (in the context of 1% albumin), the fold stimulation of insulin release from the fasted pancreas in response to 12.5 mM glucose was as follows: octanoate (C8:0), 3.4; linoleate (C18:2 cis/cis), 5.3; oleate (C18:1 cis), 9.4; palmitate (C16:0), 16. 2; and stearate (C18:0), 21.0. The equivalent value for palmitoleate (C16:1 cis) was 3.1. A cis--> trans switch of the double bond in the C16:1 and C18:1 fatty acids had only a modest, if any, impact on their potency. A similar profile emerged with regard to basal insulin secretion (3 mM glucose). When a subset of these fatty acids was tested in pancreases from fed animals, the same rank order of effectiveness at both basal and stimulatory levels of glucose was seen. The findings reaffirm the essentiality of an elevated plasma FFA concentration for GSIS in the fasted rat. They also show, however, that the insulinotropic effect of individual fatty acids spans a remarkably broad range, increasing and decreasing dramatically with chain length and degree of unsaturation, respectively. Thus, for any given level of glucose, insulin secretion will be influenced greatly not only by the combined concentration of all circulating (unbound) FFA, but also by the makeup of this FFA pool. Both factors will likely be important considerations in understanding the complex interplay between the nature of dietary fat and whole body insulin, glucose, and lipid dynamics. 相似文献
10.
Roman Perez-Soler Insook Han Salaam Al-Baker Abdul R. Khokhar 《Cancer chemotherapy and pharmacology》1994,33(5):378-384
Lipophilic diaminocyclohexane (DACH) platinum complexes have shown significant promise in preclinical studies. One of these compounds,cis-bis-neodecanoato-trans-R,R-1,2-diaminocyclohexaneplatinum(II) (NDDP), which contains two branched leaving groups of 10 carbons, showed a favorable toxicity profile in a liposomal formulation in early clinical trials. However, like many other DACH platinum compounds with branched leaving groups, it is unstable within the liposomes, thus preventing its widespread clinical evaluation. We studied the effect of the configuration of leaving groups on intraliposomal complex stability by studying a series of DACH platinum complexes containing linear alkyl carboxylato leaving groups of 5–18 carbons. The entrapment efficiency was greater than 90% for all liposomal preparations of the complexes and was independent of lipid composition and length of the leaving group. The drug leakage from the liposomes was minimal, but was directly related to the length of the leaving group. Intraliposomal stability was inversely related to the length of the leaving group and the content of DMPG (dimyristoyl phosphatidylglycerol) in the liposomes. The effect of length of leaving group on intraliposomal stability was minimal in compounds with leaving groups smaller than 10 carbons, but very pronounced in compounds with longer leaving groups. Stable liposomal formulations of selected compounds with leaving groups of 6 and 10 carbons had significant in vivo antitumor activity against both L1210/S and L1210/PDD leukemias. The results indicate (1) that compounds with linear leaving groups are much more stable within DMPG-containing liposomes than compounds with branched leaving groups and (2) that DMPG is required for in vivo antitumor activity. Stable and active liposomal formulations of selected compounds with linear leaving groups have been identified. These formulations are candidates for clinical development.Abbreviations DMPC
dimyristoyl phosphatidylcholine
- DMPG
dimyristoyl phosphatidylglycerol
- L-NDDP
liposomalcis-bis-neodecanoato-trans-1,2-diaminocyclohexaneplatinum(II)
The work reported in this paper was supported in part by NIH grants CA 41581, 45423, 50270, and 58342 相似文献